Pacific Biosciences of California, Inc. (PACB)
2.17
-0.20
(-8.44%)
USD |
NASDAQ |
Dec 11, 16:00
2.19
+0.02
(+0.92%)
After-Hours: 20:00
Pacific Biosciences of California Cash from Investing (Quarterly): 18.90M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp. | -23.80M |
| ICU Medical, Inc. | -30.03M |
| West Pharmaceutical Services, Inc. | -63.30M |
| Clearpoint Neuro, Inc. | -0.199M |
| Intellia Therapeutics, Inc. | -0.741M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.71M |
| Cash from Financing (Quarterly) | 1.469M |
| Free Cash Flow | -131.26M |
| Free Cash Flow Per Share (Quarterly) | -0.0619 |
| Free Cash Flow to Equity (Quarterly) | -19.48M |
| Free Cash Flow to Firm (Quarterly) | -16.86M |
| Free Cash Flow Yield | -20.08% |